Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab

The results reinforce other real-world evidence from several broad infant immunization programs in the US, Spain, and France.

Related Keywords

Spain ,France ,Federico Martinon Torres ,Astrazeneca ,Advisory Committee On Immunization Practices ,Vaccine Surveillance Network ,Sukjai Photo ,Universitario Santiago ,Immunization Practices ,Routine Use ,Protect Infants ,Young Children Against Respiratory Syncytial ,Address Shortage ,